Treatment algorithm

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer

ONGOING

coeliac disease

Back
1st line – 

gluten-free diet

The lifelong gluten-free diet is the only accepted treatment of coeliac disease. Consultation with a dietitian should be sought because: adherence is difficult; dietary changes may lead to deficiencies of fibre and other nutrients; the gluten-free diet can involve a higher intake of calories, simple carbohydrates, and saturated fats.[94][131]​ Patients with coeliac disease are at risk of becoming overweight/obese.[132]

Although a small percentage of people may react to avenin or cross-contamination with other gluten-containing cereals, gluten-free oats are recommended in the diet for their nutrition benefits (soluble fibre, polyunsaturated oil, vitamin B complex, and iron).[73]

Quality of life for patients with coeliac disease has been shown to improve, but not normalise, with adherence to a gluten-free diet.[133] Gluten-free diet adherence is difficult, with dietary lapses in the majority of patients.[134] The importance of the diet should be stressed, and social support should be evaluated and encouraged within the family and by membership in coeliac disease advocacy groups. 

There is substantial evidence that oats that are not contaminated by wheat or barley are safe for the vast majority of patients with coeliac disease.[148][149][150]​ Some patients may, however, be sensitive.[151] The American College of Gastroenterology guidelines recommend inclusion of gluten-free oats in diets of patients with coeliac disease.[73]

In North America, some food manufacturers operate under a 'Purity Protocol', which involves harvesting, transporting, storing, processing and manufacturing oats using processes that minimise the presence of gluten.[152] Oats are not recommended as part of a gluten-free diet in some countries, and local guidance should be consulted before recommending them.

Back
Plus – 

vitamin and mineral supplementation

Treatment recommended for ALL patients in selected patient group

Patients should be checked for common deficiencies including iron, vitamin D, vitamin B12, and folate. Deficiencies of these vitamins and minerals are more common in people with coeliac disease, compared with the general population.[135]

All patients with coeliac disease should take calcium and vitamin D supplements. Iron should only be given to individuals with iron deficiency.

Vitamin B12 (cyanocobalamin) and folate deficiencies should be corrected, especially since the gluten-free diet may be low in folate.

See Iron deficiency anaemia, Vitamin D deficiency, Vitamin B12 deficiency, and Folate deficiency.

Bone mineral density evaluation is indicated in patients with coeliac disease to assess for osteopenia or osteoporosis, but evidence regarding the optimal timing is scant. In individuals with other risk factors for osteoporosis, aged >50 years, with severe villous atrophy, a bone mineral density analysis at the time of diagnosis is indicated.[34]​ Some guidelines recommend evaluation of bone mineral density either at diagnosis or after 1 year on a gluten-free diet, as studies show that the bone density may improve on a gluten-free diet.​[73][136]​​​ Others recommend evaluation no later than ages 30-35 years, considering evidence showing a high rate of osteopenia in this population of patients with coeliac disease.​[34][137]

Doses are individualised according to age and presence of deficiencies or decreased bone density.

Primary options

ergocalciferol: 1000-2000 units orally once daily

and

calcium carbonate: 1000-1500 mg/day orally given in 3-4 divided doses

More

OR

ergocalciferol: 1000-2000 units orally once daily

and

calcium carbonate: 1000-1500 mg/day orally given in 3-4 divided doses

More

and

ferrous sulfate: 300 mg orally (immediate-release) two to four times daily

More

OR

cyanocobalamin: 1000-2000 micrograms orally once daily for 1-2 weeks, followed by 500-1000 micrograms once daily; 1000 micrograms intramuscularly/subcutaneously once daily for 1 week, followed by 1000 micrograms once weekly for 1-2 months, then 1000 micrograms once monthly; 500 micrograms into one nostril once weekly

OR

folic acid: 0.4 to 0.6 mg orally once daily

failure to respond to therapy/refractory coeliac disease

Back
1st line – 

referral to dietitian or gastroenterologist

For individuals who do not respond to a gluten-free diet, the most common problem is continued gluten exposure. There is evidence that, on a supposedly adequate gluten-free diet, patients consume enough gluten to trigger symptoms.[138][139]

The initial step in the evaluation should be repeating immunoglobulin A-tissue transglutaminase titre and referral to a dietitian with expertise in coeliac disease. If there is no evidence of continuing gluten intake, referral to a gastroenterologist with experience in the evaluation of non-responsive coeliac disease is recommended.

If symptoms persist or relapse without an alternative explanation, repeat oesophagogastroduodenoscopy and duodenal biopsies should be performed regardless of serological titres.[143]

A first-line therapy in these patients in some centres is open-capsule budesonide.[153]

The outlook for patients with refractory coeliac disease can be poor. They should be cared for at a centre experienced in coeliac disease.

Primary options

budesonide: 3 mg orally (delayed-release) three times daily

More

coeliac crisis

Back
1st line – 

rehydration + correction of electrolyte abnormalities

Coeliac crisis is rare and presents with hypovolaemia, severe watery diarrhoea, acidosis, hypocalcaemia, and hypoalbuminaemia. Patients may have a precipitating major medical event, for example, recent abdominal surgery.[145] Cases have been reported in adults and children.[146][145]​ Patients require parenteral fluid replacement and nutritional support.[145]

Back
Consider – 

corticosteroid

Additional treatment recommended for SOME patients in selected patient group

In addition to rehydration and correction of electrolyte abnormalities, patients with coeliac crisis may benefit from a short course of glucocorticoid therapy until the gluten-free diet takes effect.​[145][147]

If patients are able to take oral medications, budesonide may be used initially. If this is not effective, prednisolone or an equivalent systemic corticosteroid can be started, and should be tapered slowly after the patient is able to maintain hydration and nutritional status without intravenous supplementation.

Primary options

budesonide: 3 mg orally (delayed-release) three times daily

More

OR

prednisolone: 40-60 mg orally once daily initially then taper dose slowly

Secondary options

methylprednisolone sodium succinate: consult specialist for guidance on dose

back arrow

Choose a patient group to see our recommendations

Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer

Use of this content is subject to our disclaimer